Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy

Archives of Disease in Childhood - Tập 100 Số 6 - Trang 542-547 - 2015
Ming‐Tai Lin1, Li‐Chuan Sun2, En‐Ting Wu1, Jou‐Kou Wang1, Hung‐Chi Lue1, Mei‐Hwan Wu1
1Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University, Taipei, Taiwan
2Department of Pediatrics, Cardinal Tien General Hospital, Taipei, Taiwan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kawasaki, 1967, Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children, Arerugi, 16, 178

Nakamura, 2008, Epidemiologic features of Kawasaki disease in Japan: results of the 2005–2006 nationwide survey, J Epidemiol, 18, 167, 10.2188/jea.JE2008001

Eleftheriou, 2014, Management of Kawasaki disease, Arch Dis Child, 99, 74, 10.1136/archdischild-2012-302841

JCS Joint Working Group, 2010, Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)—digest version, Circ J, 74, 1989, 10.1253/circj.CJ-10-74-0903

Suzuki, 1997, Natural history of coronary artery lesions in Kawasaki disease, Prog Pediatr Cardiol, 6, 211, 10.1016/S1058-9813(97)00192-6

Suda, 2011, Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience, Circulation, 123, 1836, 10.1161/CIRCULATIONAHA.110.978213

Wu, 2012, Prevalence and the long-term coronary risks of patients with Kawasaki disease in a general population <40 years: a national database study, Circ Cardiovasc Qual Outcomes, 5, 566, 10.1161/CIRCOUTCOMES.112.965194

Tzen, 1997, Prognosis of coronary arterial lesions in Kawasaki disease treated without intravenous immunoglobulin, Acta Paed Sin, 38, 32

Huang, 2013, Epidemiology of Kawasaki disease: prevalence from national database and future trends projection by system dynamics modeling, J Pediatr, 163, 126, 10.1016/j.jpeds.2012.12.011

Newburger, 2004, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association, Pediatrics, 114, 1708, 10.1542/peds.2004-2182

Lin, 2011, Clinical implication of the C allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: association with disease susceptibility and BCG scar reactivation, Pediatr Infect Dis J, 30, 148, 10.1097/INF.0b013e3181f43a4e

Naoe, 1991, Kawasaki disease with particular emphasis on arterial lesions, Acta Pathol Jpn, 41, 785

Suzuki, 2000, Remodeling of coronary artery lesions due to Kawasaki disease, Jpn Heart J, 41, 245, 10.1536/jhj.41.245

Levy, 2005, Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease, J Rheumatol, 32, 928

McNeal-Davidson, 2013, The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976, Pediatr Cardiol, 34, 170, 10.1007/s00246-012-0409-2

Yanagawa, 1996, Update of the epidemiology of Kawasaki disease in Japan—from the results of 1993–94 nationwide survey, J Epidemiol, 6, 148, 10.2188/jea.6.148

Kato, 1986, Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases, J Pediatr, 108, 923, 10.1016/S0022-3476(86)80928-3

Tsuda, 2011, The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease, Pediatr Cardiol, 32, 176, 10.1007/s00246-010-9838-y

Loria, 2007, Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study, J Am Coll Cardiol, 49, 2013, 10.1016/j.jacc.2007.03.009

Smith, 2011, AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association, J Am Coll Cardiol, 58, 2432, 10.1016/j.jacc.2011.10.824

Kato, 1996, Long-term consequences of Kawasaki disease. A 10 to 21-year follow-up study of 594 patients, Circulation, 94, 1379, 10.1161/01.CIR.94.6.1379

Tsuda, 2005, Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease, Pediatr Cardiol, 26, 73, 10.1007/s00246-004-0698-1

Mavrogeni, 2013, The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease, Int J Cardiovasc Imaging, 29, 1787, 10.1007/s10554-013-0276-9